Literature DB >> 31085382

Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)

Paul A Decker1, Nicholas B Larson1, Elizabeth J Bell2, James S Pankow3, Naomi Q Hanson4, Christina L Wassel5, Michael Y Tsai4, Suzette J Bielinski6.   

Abstract

Hepatocyte growth factor (HGF) is associated with subclinical and clinical atherosclerosis. However, the significance of change in HGF and development of atherosclerotic disease is unknown. In a large and diverse population-based cohort, we report that change in the biomarker HGF is an independent predictor of incident CHD.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31085382      PMCID： PMC6581609          DOI： 10.1016/j.ahj.2019.03.018

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


  12 in total

1.  Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability.

Authors:  John E Hokanson; Todd MacKenzie; Gregory Kinney; Janet K Snell-Bergeon; Dana Dabelea; James Ehrlich; Robert H Eckel; Marian Rewers
Journal:  AJR Am J Roentgenol       Date:  2004-05       Impact factor: 3.959

2.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

3.  Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.

Authors:  Joseph Yeboah; Aaron R Folsom; Gregory L Burke; Craig Johnson; Joseph F Polak; Wendy Post; Joao A Lima; John R Crouse; David M Herrington
Journal:  Circulation       Date:  2009-07-27       Impact factor: 29.690

4.  Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure.

Authors:  Nicolas Lamblin; Sophie Susen; Joël Dagorn; Frédéric Mouquet; Brigitte Jude; Eric Van Belle; Christophe Bauters; Pascal de Groote
Journal:  Am Heart J       Date:  2005-07       Impact factor: 4.749

5.  Coronary Artery Calcium: If Measuring Once Is Good, Is Twice Better?

Authors:  Amit Khera; Philip Greenland
Journal:  Circulation       Date:  2018-02-13       Impact factor: 29.690

6.  Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Michael P Bancks; Suzette J Bielinski; Paul A Decker; Naomi Q Hanson; Nicholas B Larson; Hugues Sicotte; Christina L Wassel; James S Pankow
Journal:  Metabolism       Date:  2015-10-21       Impact factor: 8.694

7.  Hepatocyte growth factor(HGF): a new biochemical marker for acute myocardial infarction.

Authors:  T Sato; T Yoshinouchi; T Sakamoto; H Fujieda; S Murao; H Sato; H Kobayashi; T Ohe
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

8.  Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function.

Authors:  Wolfgang Lieb; Radwan Safa; Emelia J Benjamin; Vanessa Xanthakis; Xiaoyan Yin; Lisa M Sullivan; Martin G Larson; Holly M Smith; Joseph A Vita; Gary F Mitchell; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2009-02-17       Impact factor: 29.983

Review 9.  Cellular and molecular mechanisms of HGF/Met in the cardiovascular system.

Authors:  Simona Gallo; Valentina Sala; Stefano Gatti; Tiziana Crepaldi
Journal:  Clin Sci (Lond)       Date:  2015-12       Impact factor: 6.124

10.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897
View more
  5 in total

1.  Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor.

Authors:  María-Consuelo Pintado; Lara Maceda; María Trascasa; Ignacio Arribas; Raúl De Pablo
Journal:  Egypt Heart J       Date:  2022-04-28

2.  Hepatocyte growth factor is associated with greater risk of extracoronary calcification: results from the multiethnic study of atherosclerosis.

Authors:  Oluseye Ogunmoroti; Olatokunbo Osibogun; Richard A Ferraro; Paul M Ndunda; Nicholas B Larson; Paul A Decker; Suzette J Bielinski; Roger S Blumenthal; Matthew J Budoff; Erin D Michos
Journal:  Open Heart       Date:  2022-05

3.  Hepatocyte Growth Factor and Incident Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Richard A Ferraro; Oluseye Ogunmoroti; Di Zhao; Chiadi E Ndumele; Vishal Rao; Ambarish Pandey; Nicholas B Larson; Suzette J Bielinski; Erin D Michos
Journal:  J Card Fail       Date:  2021-05-26       Impact factor: 6.592

4.  Favorable Cardiovascular Health Is Associated With Lower Hepatocyte Growth Factor Levels in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Olatokunbo Osibogun; Oluseye Ogunmoroti; Richard A Ferraro; Chiadi E Ndumele; Gregory L Burke; Nicholas B Larson; Suzette J Bielinski; Erin D Michos
Journal:  Front Cardiovasc Med       Date:  2022-01-03

5.  Association of Circulating Hepatocyte Growth Factor and Risk of Incident Peripheral Artery Disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Parveen K Garg; Petra Buzkova; Christina L Wassell; Matthew Allison; Michael Criqui; Nicholas B Larson; Suzette J Bielinski
Journal:  Angiology       Date:  2020-03-23       Impact factor: 3.619
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.